Clinical Trial Update: Safety of and Immune Response to a Prime-Boost Vaccine Regimen in HIV-Uninfected Vaccine-Naive Adults [Phase 2]

View source ↗

Summary

Phase 2 clinical trial assessing safety and immune response of a prime-boost vaccine regimen in HIV-uninfected, vaccine-naive adults.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection

Snippet

Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) | Conditions: HIV Infections | Phase 2 | Status: COMPLETED